Stockscreener 앱 받기
0.8002
1.83%
-0.0149
시간 외 거래:
.80
-0.0002
-0.02%
전일 마감가:
$0.8151
열려 있는:
$0.8221
하루 거래량:
158.94K
Relative Volume:
0.35
시가총액:
$53.72M
수익:
-
순이익/손실:
$-46.12M
주가수익비율:
-0.9259
EPS:
-0.8642
순현금흐름:
$-41.02M
1주 성능:
-6.95%
1개월 성능:
-8.64%
6개월 성능:
-67.60%
1년 성능:
-40.28%
1일 변동 폭
$0.7809
$0.86
1주일 범위
$0.7406
$0.9242
52주 변동 폭
$0.7113
$2.815
Inflarx N V Stock (IFRX) Company Profile
IFRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IFRX
Inflarx N V
|
0.8002 | 56.91M | 0 | -46.12M | -41.02M | -0.8642 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Inflarx N V Stock (IFRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-29 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-05 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-02-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-10-28 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-03-11 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-11-06 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-10-08 | 개시 | H.C. Wainwright | Buy |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-04-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2019-06-05 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2019-06-05 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-06-05 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2019-06-05 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-06-05 | 다운그레이드 | SunTrust | Buy → Hold |
| 2019-01-29 | 개시 | Robert W. Baird | Outperform |
| 2018-12-10 | 개시 | Credit Suisse | Outperform |
| 2018-07-13 | 개시 | BMO Capital Markets | Outperform |
| 2018-06-28 | 개시 | Raymond James | Outperform |
| 2018-06-28 | 개시 | SunTrust | Buy |
| 2018-02-08 | 개시 | B. Riley FBR, Inc. | Buy |
모두보기
Inflarx N V 주식(IFRX)의 최신 뉴스
Sentiment analysis tools applied to InflaRx N.V.Daily Stock Movement Forecast with Accuracy - Newser
Is it time to cut losses on InflaRx N.V.Free Entry Alert With Low Drawdown Strategy - Newser
Published on: 2025-08-10 03:26:25 - Newser
InflaRx N.V. stock momentum explainedMonthly Trade Result and Signal Summary - Newser
InflaRx N.V. stock chart pattern explainedFree Breakout Momentum Picks With Protection - Newser
How high can InflaRx N.V. stock goGrowth Watchlist for Long Term Positioning - Newser
Key resistance and support levels for InflaRx N.V.Downside Risk Evaluation and Stock Analysis - Newser
Is InflaRx N.V. stock reversal real or fakeFree Trend Following Strategy With Stop Loss - Newser
Is InflaRx N.V. Stock a Good Fit for Conservative InvestorsFree Community Strategy With High Win Rate - Newser
Real time social sentiment graph for InflaRx N.V.High Yield Watchlist with Filtered Picks - Newser
Why InflaRx N.V. stock attracts strong analyst attentionShort-Term Upside Breakout Forecast System - Newser
Sector ETF performance correlation with InflaRx N.V.Consistent Gain Plan with AI Support - Newser
InflaRx NV reports results for the quarter ended June 30Earnings Summary - TradingView
InflaRx N.V. (IFRX) Reports Q2 Loss, Misses Revenue Estimates - ca.finance.yahoo.com
InflaRx Reports Significant Losses in H1 2025 Financials - TipRanks
InflaRx Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Applying chart zones and confluence areas to InflaRx N.V.Technical Setup Guide for Daily Watchlist - Newser
Is it time to cut losses on InflaRx N.VFree Fast Exit and Entry Strategy Guide - Newser
What to do if you’re stuck in InflaRx N.V.Trade Safety Matrix for Conservative Traders - Newser
Understanding InflaRx N.V.’s price movementPrice Action Based Buy Zone Forecast - Newser
Tools to assess InflaRx N.V.’s risk profileFree Profit Target Stock Opportunity Monitor - Newser
What MACD signals say about InflaRx N.V.Free Beginner Friendly Stock Selection Guide - Newser
What are analysts’ price targets for InflaRx N.V. in the next 12 monthsUnlock powerful portfolio management tools - Jammu Links News
How does InflaRx N.V. compare to its industry peersMaximize portfolio returns with smart trading - Jammu Links News
What drives InflaRx N.V. stock priceFree Stock Market Return Analysis - Jammu Links News
Should I hold or sell InflaRx N.V. stock in 2025Invest smarter with expert trading signals - Jammu Links News
What is InflaRx N.V. company’s growth strategyTransform your portfolio with high-yield stocks - Jammu Links News
What are the latest earnings results for InflaRx N.V.Consistent high-performance stocks - Jammu Links News
Applying Elliott Wave Theory to InflaRx N.V.Free Scalable Portfolio Growth Suggestions - Newser
Inflarx N V (IFRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):